We use a few cookies

Essential cookies keep the library working. With your permission, we'd also like to use analytics to see what's useful and improve the experience. Read our Privacy Policy or Cookie Policy.

Skip to main content
Home/e-Resources/Biotechnology/Present and Future of Personalised Medicine for Endocrine Cancers
BooksBiotechnology

Present and Future of Personalised Medicine for Endocrine Cancers

Checking your access to this record.

Abstract & Overview

Major technological advances in genomics have made it possible to identify critical genetic alterations in cancer, rendering oncology well along the path to “personalised cancer medicine”. Thanks to developments in genetics, several mutations and gene rearrangements have been identified in patients with endocrine cancers (e.g., thyroid and adrenocortical carcinoma). In particular, each patient can be considered as a unique, individual one, with unique genetic information. The aim of this Special Issue is to offer an overview of exciting new research in the area of endocrine tumours may set the stage for an innovative personalised management and precision medicine modalities for individualised care.New affordable individual genomic analyses, as well as the opportunity to test new compounds in primary cells may allow a personalised management of patients with endocrine malignancies. This approach may improve the prediction of clinical outcome and therapeutic effectiveness, as well as help to avoid the use of ineffective drugs. However, further efforts are needed to obtain an adjustment of clinical management in patients with endocrine cancers that would rely solely or in great part on genetic information. This Special Issue includes basic, translational, and clinical papers on personalised medicine in endocrine malignancies (i.e., thyroid and adrenal), especially focusing on diagnostic and prognostic biomarkers, as well as novel drug targets or targeted treatments, including eventual clinical trials.

Cite this record

Ronchi, Cristina L., Altieri, Barbara (2022). Present and Future of Personalised Medicine for Endocrine Cancers. MDPI - Multidisciplinary Digital Publishing Institute. https://library.shubhaarti.com/content/2e04e218-0c0f-41b6-bcc8-328db5ee22cf

Copy in another style

L., R. C., & Barbara, A. (2022). Present and Future of Personalised Medicine for Endocrine Cancers. MDPI - Multidisciplinary Digital Publishing Institute. https://library.shubhaarti.com/content/2e04e218-0c0f-41b6-bcc8-328db5ee22cf
Author names are used as deposited, so check their order before you submit.

Metadata is harvested from open-access indexes and can be incomplete. Check a citation against the published version before relying on it — see our open access & attribution policy.